Matches in SemOpenAlex for { <https://semopenalex.org/work/W1910908492> ?p ?o ?g. }
- W1910908492 endingPage "526" @default.
- W1910908492 startingPage "517" @default.
- W1910908492 abstract "BACKGROUND Overexpression of NUSAP1 is associated with poor prognosis in prostate cancer, but little is known about what leads to its overexpression. Based on previous observations that NUSAP1 expression is enhanced by E2F1, we hypothesized that NUSAP1 expression is regulated, at least in part, by loss of RB1 via the RB1/E2F1 axis. METHODS Using Significance Analysis of Microarrays, we examined RB1 , E2F1 , and NUSAP1 transcript levels in prostate cancer gene expression datasets. We compared NUSAP1 expression levels in DU145, LNCaP, and PC‐3 prostate cancer cell lines via use of cDNA microarray data, RT‐qPCR, and Western blots. In addition, we used lentiviral expression constructs to knockdown RB1 in prostate cancer cell lines and transient transfections to knockdown E2F1 , and investigated RB1 , E2F1 , and NUSAP1 expression levels with RT‐qPCR and Western blots. Finally, in DU145 cells or PC‐3 cells that stably underexpress RB1 , we used proliferation and invasion assays to assess whether NUSAP1 knockdown affects proliferation or invasion. RESULTS NUSAP1 transcript levels are positively correlated with E2F1 and negatively correlated with RB1 transcript levels in prostate cancer microarray datasets. NUSAP1 expression is elevated in the RB1‐null DU145 prostate cancer cell line, as opposed to LNCaP and PC‐3 cell lines. Furthermore, NUSAP1 expression increases upon knockdown of RB1 in prostate cancer cell lines (LNCaP and PC‐3) and decreases after knockdown of E2F1 . Lastly, knockdown of NUSAP1 in DU145 cells or PC‐3 cells with stable knockdown of RB1 decreases proliferation and invasion of these cells. CONCLUSION Our studies support the notion that NUSAP1 expression is upregulated by loss of RB1 via the RB1/E2F1 axis in prostate cancer cells. Such upregulation may promote prostate cancer progression by increasing proliferation and invasion of prostate cancer cells. NUSAP1 may thus represent a novel therapeutic target. Prostate 75: 517–526, 2015 . © 2015 Wiley Periodicals, Inc." @default.
- W1910908492 created "2016-06-24" @default.
- W1910908492 creator A5014002782 @default.
- W1910908492 creator A5022762690 @default.
- W1910908492 creator A5073984054 @default.
- W1910908492 date "2015-01-13" @default.
- W1910908492 modified "2023-10-16" @default.
- W1910908492 title "<i>NUSAP1</i>expression is upregulated by loss of RB1 in prostate cancer cells" @default.
- W1910908492 cites W1966559042 @default.
- W1910908492 cites W1972032922 @default.
- W1910908492 cites W1983012321 @default.
- W1910908492 cites W1985534107 @default.
- W1910908492 cites W1988294855 @default.
- W1910908492 cites W1990786456 @default.
- W1910908492 cites W1993624611 @default.
- W1910908492 cites W1998343146 @default.
- W1910908492 cites W2000056288 @default.
- W1910908492 cites W2003955264 @default.
- W1910908492 cites W2006157165 @default.
- W1910908492 cites W2007796732 @default.
- W1910908492 cites W2020729244 @default.
- W1910908492 cites W2022635468 @default.
- W1910908492 cites W2022731471 @default.
- W1910908492 cites W2024432096 @default.
- W1910908492 cites W2024861525 @default.
- W1910908492 cites W2025380058 @default.
- W1910908492 cites W2034277114 @default.
- W1910908492 cites W2035159808 @default.
- W1910908492 cites W2036877110 @default.
- W1910908492 cites W2051006651 @default.
- W1910908492 cites W2055162988 @default.
- W1910908492 cites W2060725528 @default.
- W1910908492 cites W2066911215 @default.
- W1910908492 cites W2067257063 @default.
- W1910908492 cites W2068443072 @default.
- W1910908492 cites W2069969538 @default.
- W1910908492 cites W2070996651 @default.
- W1910908492 cites W2072320617 @default.
- W1910908492 cites W2083003255 @default.
- W1910908492 cites W2084200924 @default.
- W1910908492 cites W2086416171 @default.
- W1910908492 cites W2086629202 @default.
- W1910908492 cites W2089518544 @default.
- W1910908492 cites W2095873383 @default.
- W1910908492 cites W2107059185 @default.
- W1910908492 cites W2107633226 @default.
- W1910908492 cites W2108426942 @default.
- W1910908492 cites W2113962581 @default.
- W1910908492 cites W2119504728 @default.
- W1910908492 cites W2119752676 @default.
- W1910908492 cites W2131357804 @default.
- W1910908492 cites W2132005771 @default.
- W1910908492 cites W2135798683 @default.
- W1910908492 cites W2136961873 @default.
- W1910908492 cites W2147200519 @default.
- W1910908492 cites W2151834630 @default.
- W1910908492 cites W2152616419 @default.
- W1910908492 cites W2161817637 @default.
- W1910908492 cites W2166666333 @default.
- W1910908492 cites W2167899505 @default.
- W1910908492 doi "https://doi.org/10.1002/pros.22938" @default.
- W1910908492 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25585568" @default.
- W1910908492 hasPublicationYear "2015" @default.
- W1910908492 type Work @default.
- W1910908492 sameAs 1910908492 @default.
- W1910908492 citedByCount "37" @default.
- W1910908492 countsByYear W19109084922016 @default.
- W1910908492 countsByYear W19109084922017 @default.
- W1910908492 countsByYear W19109084922018 @default.
- W1910908492 countsByYear W19109084922019 @default.
- W1910908492 countsByYear W19109084922020 @default.
- W1910908492 countsByYear W19109084922021 @default.
- W1910908492 countsByYear W19109084922022 @default.
- W1910908492 countsByYear W19109084922023 @default.
- W1910908492 crossrefType "journal-article" @default.
- W1910908492 hasAuthorship W1910908492A5014002782 @default.
- W1910908492 hasAuthorship W1910908492A5022762690 @default.
- W1910908492 hasAuthorship W1910908492A5073984054 @default.
- W1910908492 hasConcept C121608353 @default.
- W1910908492 hasConcept C173396325 @default.
- W1910908492 hasConcept C2776438761 @default.
- W1910908492 hasConcept C2779723316 @default.
- W1910908492 hasConcept C2780192828 @default.
- W1910908492 hasConcept C502942594 @default.
- W1910908492 hasConcept C54355233 @default.
- W1910908492 hasConcept C81885089 @default.
- W1910908492 hasConcept C86803240 @default.
- W1910908492 hasConceptScore W1910908492C121608353 @default.
- W1910908492 hasConceptScore W1910908492C173396325 @default.
- W1910908492 hasConceptScore W1910908492C2776438761 @default.
- W1910908492 hasConceptScore W1910908492C2779723316 @default.
- W1910908492 hasConceptScore W1910908492C2780192828 @default.
- W1910908492 hasConceptScore W1910908492C502942594 @default.
- W1910908492 hasConceptScore W1910908492C54355233 @default.
- W1910908492 hasConceptScore W1910908492C81885089 @default.
- W1910908492 hasConceptScore W1910908492C86803240 @default.
- W1910908492 hasFunder F4320306078 @default.
- W1910908492 hasIssue "5" @default.